Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 20;9(1):167.
doi: 10.1186/s40249-020-00763-7.

Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts

Affiliations

Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts

Pedro Henrique Ferreira Marçal et al. Infect Dis Poverty. .

Abstract

Background: Leprosy is a chronic infectious disease classified into two subgroups for therapeutic purposes: paucibacillary (PB) and multibacillary (MB), closely related to the host immune responses. In this context it is noteworthy looking for immunological biomarkers applicable as complementary diagnostic tools as well as a laboratorial strategy to follow-up leprosy household contacts.

Methods: The cross-sectional study enrolled 49 participants, including 19 patients and 30 healthy controls. Peripheral blood mononuclear cells (PBMC) were isolated and incubated in the presence of Mycobacterium leprae bacilli. The cells were prepared for surface (CD4+ and CD8+) and intracytoplasmic cytokine staining (IFN-γ, IL-4 and IL-10). Multiple comparisons amongst groups were carried out by ANOVA, Kruskal-Wallis, Student T or Mann-Whitney test. Comparative analysis of categorical variables was performed by Chi-square. Functional biomarker signature analysis was conducted using the global median values for each biomarker index as the cut-off edge to identify the proportion of subjects with high biomarker levels.

Results: The cytokine signature analysis demonstrated that leprosy patients presented a polyfunctional profile of T-cells subsets, with increased frequency of IFN-γ+ T-cell subsets along with IL-10+ and IL-4+ from CD4+ T-cells, as compared to health Controls (Venn diagram report). Moreover, statistical analysis was carried out using parametric or non-parametric variance analysis followed by pairwise multiple comparisons, according to the data normality distribution. L(PB) displayed a polyfunctional profile characterized by enhanced percentage of IFN-γ+, IL-10+ and IL-4+ produced by most T-cell subsets, as compared to L(MB) that presented a more restricted cytokine functional profile mediated by IL-10+ and IL-4+ T-cells with minor contribution of IFN-γ produced by CD4+ T-cells. Noteworthy was that HHC(MB) exhibited enhanced frequency of IFN-γ+ T-cells, contrasting with HHC(PB) that presented a cytokine profile limited to IL-10 and IL-4.

Conclusions: Our data demonstrated that L(PB) displayed enhanced percentage of IFN-γ+, IL-10+ and IL-4+ as compared to L(MB) that presented functional profile mediated by IL-10+ and IL-4+ T-cells and HHC(MB) exhibited enhanced frequency of IFN-γ+ T-cells, contrasting with HHC(PB). Together, our findings provide additional immunological features associated with leprosy and household contacts. These data provide evidence that biomarkers of immune response can be useful complementary diagnostic/prognostic tools as well as insights that household contacts should be monitored to access putative subclinical infection.

Keywords: Cytokines; Household contacts; Leprosy; Mycobacterium leprae.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Frequency of cytokine+ cells in Leprosy patients, Household Contacts and Healthy Controls upon in vitro non-stimulated culture. The frequency (‰) of cytokine+ cells (IFN-γ, IL-4 and IL-10) amongst gated lymphocyte subsets including: T-cells, CD4+ T-cells and CD8+ T-cells were calculated upon in vitro culture in the absence of exogenous stimuli (non-stimulated culture). The results are presented in boxplot format, indicating the median values (min–max) and the outliers underscored by dots, based on Tuckey analysis for Healthy Controls =  formula image ; Leprosy patients =  formula image ; HHC(PB) =  formula image —Household Contacts of Paucibacillary Leprosy patients; HHC(MB) =  formula image —Household Contacts of Multibacillary Leprosy patients; L(PB) =  formula image —Paucibacillary Leprosy patients; L(MB) =  formula image —Multibacillary Leprosy patients. Multiple comparisons amongst groups were carried out by Kruskal–Wallis test followed by Dunn’s post-test for sequential pairwise comparisons. Additionally, Man-Whitney Test were also employed for pairwise comparative analysis. Significant differences, using the above-mentioned statistical methods are underscored by * for differences at P < 0.05 and ** for differences at P < 0.01
Fig. 2
Fig. 2
Frequency of cytokine+ cells in Leprosy patients, Household Contacts and Healthy Controls upon in vitro M. leprae-stimulated culture. The frequency (‰) of cytokine+ cells (IFN-γ, IL-4 and IL-10) amongst gated lymphocyte subsets including: T-cells, CD4+ T-cells and CD8+ T-cells were calculated upon in vitro culture in the absence of exogenous stimuli (non-stimulated culture). The results are presented in boxplot format, indicating the median values (min–max) and the outliers underscored by dots, based on Tuckey analysis for Healthy Controls =  formula image ; Leprosy patients =  formula image ; HHC(PB) =  formula image —Household Contacts of Paucibacillary Leprosy patients; HHC(MB) =  formula image —Household Contacts of Multibacillary Leprosy patients; L(PB) =  formula image —Paucibacillary Leprosy patients; L(MB) =  formula image —Multibacillary Leprosy patients. Multiple comparisons amongst groups were carried out by Kruskal–Wallis test followed by Dunn’s post-test for sequential pairwise comparisons. Additionally, Man-Whitney Test were also employed for pairwise comparative analysis. Significant differences, using the above-mentioned methods, are underscored by * for differences at P < 0.05 and ** for differences at P < 0.01
Fig. 3
Fig. 3
Functional biomarker signatures in Leprosy patients and Healthy Controls. a Overlaid biomarker signatures of Leprosy patients ( formula image ) and Controls ( formula image ) were assembled to select biomarkers with proportion of subjects above the global median cut-off higher than the 50% in each group (black/white background rectangles). b Venn diagram report was employed to identify the set of biomarkers selectively increased in Leprosy patients as compared to Healthy Controls. These attributes were tagged in bold format
Fig. 4
Fig. 4
Functional biomarker signatures in subgroups of Leprosy patients and Household contacts. a Overlaid biomarker signatures of subgroups of Household contacts (HHC(PB) =  formula image and HHC(MB) =  formula image ) and subgroups of Leprosy patients (L(PB) =  formula image and L(MB) =  formula image ) were assembled to select biomarkers above the global median cut-off with proportion higher than the 50% in each group (black/white background rectangles). These attributes were tagged in bold format. b Venn diagram report was employed to identify the set of biomarkers selectively increased in each subgroup of Household contacts and subgroups of Leprosy patients. These attributes were highlighted in bold underline format

Similar articles

Cited by

References

    1. WHO Global leprosy update, 2017: accelerating reduction of disease burden. Wkly Epidemiol Rec. 2017;2018(93):445.
    1. Ahuja M, Lavania M, Singh I, et al. Detection of Mycobacterium lepromatosis in patients with leprosy in India. Infect Drug Resist. 2018;1677:1683. - PMC - PubMed
    1. Pinheiro RO, de Souza SJ, Sarno EN, Sampaio EP. Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview. Future Microbiol. 2011;217:230. - PMC - PubMed
    1. Bhat RM, Prakash C. Leprosy: an overview of pathophysiology. Interdiscip Perspect Infect Dis. 2012;1:6. - PMC - PubMed
    1. Contin LA, Alves CJ, Fogagnolo L, Nassif PW, Barreto JA, Lauris JR, Nogueira ME. Use of the ML-Flow test as a tool in classifying and treating leprosy. An Bras Dermatol. 2011;91:95. - PubMed